Table 1.
Distribution of the thyroid disorders after COVID-19 vaccination according to the vaccine type
| Thyroid disorders | mRNA-based vaccines | Vector-based vaccines | Inactivated vaccines | Total |
|---|---|---|---|---|
| Subacute thyroiditisa | 31 | 6 | 12 | 50 (60.2%) |
| Graves’ disease | 16 | 5 | – | 21 (25.3%) |
| Focal painful thyroiditis | 3 | – | – | 3 (3.6%) |
| Silent thyroiditis | 3 | - | – | 3 (3.6%) |
| Concurrent GD and SAT | 1 | 1 | – | 2 (2.4%) |
| Thyroid eye disease | 1 | – | – | 1 (1.2%) |
| Painless thyroiditis with TPP | – | 1 | – | 1 (1.2%) |
| Overt hypothyroidism | 1 | – | – | 1 (1.2%) |
| Atypical subacute thyroiditis | 1 | – | – | 1 (1.2%) |
| Total | 57 (68.7%) | 13 (15.7%) | 12 (14.5%) | 83 (100.0%) |
GD Graves' disease, SAT Subacute thyroiditis, TPP thyrotoxic periodic paralysis
aThe vaccine type was not reported for 1 patient with subacute thyroiditis